GE Healthcare and Alibaba DAMO Academy Sign Agreement to Jointly Explore "One-Scan Multi-Detection" Medical AI

Deep News
Nov 06

At the 8th China International Import Expo held in Shanghai, GE Healthcare and Alibaba DAMO Academy officially signed a cooperation framework agreement. The two parties aim to integrate DAMO Academy's pioneering "One-Scan Multi-Detection" medical AI technology into GE Healthcare's advanced imaging equipment, creating an integrated hardware-software solution for intelligent and precise diagnostics while accelerating its implementation.

This marks the first collaboration between Alibaba DAMO Academy and a medical equipment manufacturer, signaling its push toward large-scale adoption of "One-Scan Multi-Detection" AI. DAMO Academy has long focused on using AI to identify subtle lesions in non-contrast CT scans, achieving breakthroughs in screening for major diseases such as pancreatic cancer, gastric cancer, and aortic dissection. Its research has been published three times in the prestigious medical journal *Nature Medicine* and received the U.S. FDA's "Breakthrough Device Designation" (BDD). To date, DAMO Academy has provided medical AI services to healthcare institutions in nine countries and regions, covering over 50 million cases.

GE Healthcare operates in more than 160 countries and regions. Since introducing its first X-ray machine to China in 1897, the company has established over 30 offices, six production bases (including seven factories), and three "Innovation Centers" in Beijing, Wuxi, and Shanghai to meet the growing demand for high-quality medical services in China.

The collaboration will combine GE Healthcare's expertise in high-end medical equipment manufacturing and digital solutions with DAMO Academy's cutting-edge AI capabilities and "One-Scan Multi-Detection" technology to bridge the hardware-software gap. This integration will enable a single CT scan to detect multiple cancers, acute conditions, and chronic diseases—particularly those traditionally difficult to identify via non-contrast CT, such as gastrointestinal tumors and aortic dissection—thereby expanding diagnostic coverage while improving accuracy, efficiency, and accessibility. Moving forward, both parties will jointly optimize models, explore new methodologies, and advance productization efforts.

Sun Xuguang, Chief Technology Officer of GE Healthcare China, stated: "Leveraging years of technological expertise and industry experience, GE Healthcare has deeply integrated AI into the entire imaging chain, driving the evolution of medical imaging into the deep-learning AI era. We look forward to partnering with leading institutions like Alibaba DAMO Academy to enhance the innovation ecosystem, developing smarter, more user-friendly, and efficient integrated solutions that empower clinicians and benefit patients through precision diagnostics."

Zhang Jianfeng, Dean of Alibaba DAMO Academy, added: "Medical imaging is a key frontier for AI innovation in healthcare. Since its inception, DAMO Academy has prioritized medical AI, achieving groundbreaking progress in AI-based screening for critical diseases. We are excited to collaborate with GE Healthcare to accelerate the fusion of medical AI and high-end devices, ensuring cutting-edge technology reaches broader populations as quickly as possible."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10